Case Study: Transforming Global Duchenne Muscular Dystrophy Care

MedAll was used to deliver practice changing global education in a rare disease: at scale.

pharma2.png

Measurable Success

The results of the initiative were compelling

4 millionProgram Reach
67Countries
4.8kRegistered HCPs

Utilizing MedAll's desktop and app the initiative delivered practice-changing HCP engagement

Insights

Our highly targeted custom insights measure more than just clicks and helps us truly understand HCPs' needs.
– Sentiment analyses
– Questionnaires
– Polls
– Interviews
– Engagement analysis
– Feedback

Community-building

HCPs were reached when they were at their most engaged
– Peer-to peer knowledge sharing
– Case and topic discussions
– Custom MedAll community around the therapy area
– Interactive Q&A with experts

Content

Highlight specific disease areas with exceptional content:
– CME content production with accreditation
– Live virtual events
– Enduring micro-learning content in multiple languages
– Case discussions led by KOLs

Reach

The initiative was kept front of mind with HCPs on our peer-to-peer app, helping deliver sustained changes in practice.
– Banners
– Content digests
– Tailored mobile notifications

A Global Challenge

Our groundbreaking initiative in Duchenne Muscular Dystrophy aimed to transform the proficiency of healthcare professionals across continents. Targeting global regions with pressing healthcare needs, MedAll reached 67 countries with vital DMD education.

pharma2.jpg
HomeHero1.png

Education with Impact

Our primary objective was to enhance HCPs' capabilities in early DMD detection and management, ensuring early and effective interventions. This initiative was not just about disseminating information but about equipping frontline professionals with the tools to make a tangible difference.

Innovative and Inclusive

Leveraging MedAll’s advanced platform, the program delivered a multi-faceted, multilingual, ACCME-accredited program through interactive sessions and on-demand micro-learning case-based modules, ensuring no HCP was left behind regardless of location.

pharma2.jpg

A program with real-world impact

Post-program analysis revealed significant enhancements in DMD clinical practice:
we measure what really matters.

Improved early diagnosis

A significant improvement was demonstrated in the competency of HCPs detecting and diagnosing DMD early.

Faster evaluations by specialists

Specific improvement in integrating with existing referral networks, including pediatric neurologists, neuromuscular specialists, and geneticists.

Reducing urban-rural inequalities

The program provided frameworks to support HCPs use of telemedicine to reduce inequalities in access to neuromuscular specialists.

Evidence-Based Treatment Protocols

Improved use of current clinical guidelines, as well as evaluation and modification of treatment protocols regularly, based on response and new scientific evidence, ensuring optimal care.

Don't just take our word for it

Attendees described the program as comprehensive, well-structured and enjoyable.

This program was so good: it covered every area we needed.

It was really well structured. I enjoyed it thoroughly.

Everything was on point and nicely done. Kudos.

Join Our Mission

We invite companies to truly make an impact by supporting healthcare professionals with impactful, engaging content. Let’s expand the reach and deepen the impact of such vital educational resources together. Enhance your impact with by deliverinbg content that really matters.